Medical Comorbidity & C-L Psychiatry at AAPP 2027 Annual Meeting
5 sessions on medical comorbidity & c-l psychiatry · April 4–7, 2027, Louisville, KY. Compare medical comorbidity & c-l psychiatry at other meetings →
Monday, April 5
08:00–09:00 · Lecture · Clinical Application Series
Mental Health Care in Oncology: Highlighting a Lived Experience
A session drawing on a patient's lived experience and current evidence to examine anxiety, depression and distress in people with cancer. It covers barriers to integrated mental health care and the psychiatric pharmacist's role in supporting patients, including menopause related to cancer treatment.
Anxiety Disorders · Collaborative & Integrated Care · Depression
14:50–15:50 · Lecture · Clinical Application Series
Neuropsychiatric Comorbidities of Multiple Sclerosis
Covers how common psychiatric symptoms present in people with multiple sclerosis and reviews the safety and efficacy of pharmacologic options given limited evidence. Focuses on choosing individualized treatment regimens for co-occurring psychiatric symptoms.
Tuesday, April 6
12:20–13:20 · Lecture · Clinical Application Series
Managing Psychiatric Symptoms in Neurogenetic Syndromes
Reviews psychiatric and behavioral symptoms seen in neurogenetic syndromes and the evidence for pharmacologic treatment, including emerging options. Covers safety, ethical considerations and building patient-centered, stewardship-oriented treatment plans.
Autism & Neurodevelopmental Disorders · Child & Adolescent · Pharmacogenomics & Precision Psychiatry
13:30–14:30 · Lecture · Clinical Application Series
Antiseizure Medications in Neuropsychiatric Practice: Identifying, Preventing, and Managing Adverse Effects
Online course on the systemic and neuropsychiatric adverse effects of antiseizure medications, covering patient-specific risk factors and strategies to prevent, identify and manage problems. Emphasizes individualized treatment plans to improve safety and adherence.
14:50–15:50 · Lecture
Testosterone Across the Male Lifespan and Implications for Mental Health
Covers how testosterone changes across a man's life and how it relates to mood, anxiety and cognition. Reviews neurotransmitter mechanisms, patient selection for screening, and the benefits, limits and risks of testosterone replacement therapy.
Other topics at this meeting
Drug Interactions & Safety 5Practice, Policy & Workforce 5Antipsychotic Prescribing 4Anxiety Disorders 4Collaborative & Integrated Care 4Education & Training 4Schizophrenia & Psychosis 4Deprescribing & Polypharmacy 3Depression 3Measurement-Based Care & Diagnosis 3Pharmacogenomics & Precision Psychiatry 3Child & Adolescent 2